跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
科跃奇 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Recombinant Coagulation Factor VIII for Injection
Approved
生物制品
Recombinant Coagulation Factor VIII for Injection
BAYER HEALTHCARE LLC
🇨🇳 National Medical Products Administration
Approval Date
Jan 20, 2023
Approval ID
7136459f47fea0fb
Company
BAYER HEALTHCARE LLC
Type
生物制品
Approval Details
Approval Id
7136459f47fea0fb
Approval Number
国药准字SJ20180016
Generic Name
注射用重组人凝血因子Ⅷ
Generic Name En
Recombinant Coagulation Factor VIII for Injection
Trade Name
科跃奇
Drug Type
生物制品
Dosage Form
注射剂
Strength
250IU/瓶
Reg Date
2023-01-20
Expired Date
2028-01-19
Company Name
BAYER HEALTHCARE LLC
Production Company Name
BAYER HEALTHCARE LLC
Company Detail Path
/organization/bayer-healthcare-llc
Production Company Detail Path
/organization/bayer-healthcare-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 20, 2023
Approval ID
7136459f47fea0fb
Type
生物制品
Back to NMPA Approvals
